SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-17-089308
Filing Date
2017-03-20
Accepted
2017-03-20 16:03:03
Documents
2
Group Members
ADAM SPEARSANSON ADVISORS INC.ANSON MANAGEMENT GP LLCBRUCE R. WINSONMOEZ KASSAM

Document Format Files

Seq Description Document Type Size
1 SC 13G d330126dsc13g.htm SC 13G 107220
2 EX-99.1 d330126dex991.htm EX-99.1 8302
  Complete submission text file 0001193125-17-089308.txt   117282
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Subject) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85368 | Film No.: 17701417
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5950 BERKSHIRE LANE SUITE 210 DALLAS TX 75225
Business Address 5950 BERKSHIRE LANE SUITE 210 DALLAS TX 75225 214.866.0202
Anson Funds Management LP (Filed by) CIK: 0001491072 (see all company filings)

IRS No.: 300134498 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G